| Characteristics of the initial patients hospitalized for COVID-19: a single-center report A Medetalibeyoğlu, N Şenkal, G Capar, M Köse, T Tükek Turkish journal of medical sciences 50 (5), 1436-1439, 2020 | 17 | 2020 |
| Relationships among oncostatin M, insulin resistance, and chronic inflammation: a pilot study M Akarsu, M Hurşitoğlu, Z Toprak, ŞA Yoldemir, Ö Altun, ID Toprak, ... Archives of endocrinology and metabolism 64, 38-44, 2019 | 8 | 2019 |
| Endovascular repair of iliac artery aneurysms: a single center experience in 10-Years OS Göksel, E Gök, A Önalan, K Güven, G Çapar, B Çınar, U Alpagut Forum Multimedia Publishing, Llc, 2019 | 7 | 2019 |
| The effects of overt hypothyroidism on adipose tissue and serum betatrophin levels M Akarsu, ŞA YOLDEMİR, Ö Altun, O Dikker, M Özcan, EÖ Çil, S Kalyon, ... Journal of Surgery and Medicine 3 (9), 631-634, 2019 | 2 | 2019 |
| THE PROGNOSTIC SIGNIFICANCE OF NEUTROPHIL-TOLYMPHOCYTE RATIO PATIENTS WITH LYMPHOMA A Medetalibeyoğlu, M Ateş, M Altınkaynak, G Capar, S Bayrakdar, ... Journal of Istanbul Faculty of Medicine 84 (1), 40-47, 2021 | | 2021 |
| Madde Kullanım Bozukluğunda CYP3A4* 1B Gen Varyantının Rolü Ç Gazi, ŞÇ Hayriye, P Sacide Sağlık Bilimlerinde İleri Araştırmalar Dergisi 3 (3), 130-134, 2020 | | 2020 |
| Role of CYP3A4* 1B Gene Variant In Substance Use Disorder G Çapar, HŞ Çiftçi, S Pehlivan Sağlık Bilimlerinde İleri Araştırmalar Dergisi 3 (3), 130-134, 2020 | | 2020 |
| Serum endotrophin levels in heart failure patients with reduced ejection fraction; a preliminary study G Capar, H Eruzun, Y Arman, I Toprak, U Yilmaz, O Kutlu, I Aslan, ... EUROPEAN JOURNAL OF HEART FAILURE 21, 24-24, 2019 | | 2019 |
| Role of CYP3A4* 1B Gene Variant In Substance Use Disorder Madde Kullanım Bozukluğunda CYP3A4* 1B Gen Varyantının Rolü G Çapar, HŞ Çiftçi, S Pehlivan | | |
